These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10721942)

  • 41. The relationship between lymphatic vessell invasion, tumor size, and pathologic nodal status: can we predict who can avoid a third field in the absence of axillary dissection?
    Wong JS; O'Neill A; Recht A; Schnitt SJ; Connolly JL; Silver B; Harris JR
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):133-7. PubMed ID: 10924982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predicting axillary sentinel node status in patients with primary breast cancer.
    Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
    Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improving the Accuracy of Axillary Lymph Node Surgery in Breast Cancer with Ultrasound-Guided Wire Localization of Biopsy Proven Metastatic Lymph Nodes.
    Plecha D; Bai S; Patterson H; Thompson C; Shenk R
    Ann Surg Oncol; 2015 Dec; 22(13):4241-6. PubMed ID: 25814365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reasons for failure to identify positive sentinel nodes in breast cancer patients with significant nodal involvement.
    de Kanter AY; Menke-Pluijmers MB; Henzen-Logmans SC; van Geel AN; van Eijck CJ; Wiggers T; Eggermont AM
    Eur J Surg Oncol; 2006 Jun; 32(5):498-501. PubMed ID: 16580810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
    Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
    J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sentinel lymphadenectomy for breast cancer in a community managed care setting.
    Guenther JM; Krishnamoorthy M; Tan LR
    Cancer J Sci Am; 1997; 3(6):336-40. PubMed ID: 9403045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
    Crossin JA; Johnson AC; Stewart PB; Turner WW
    Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Identification of sentinel lymph node in breast cancer: experience from the Institut Curie].
    Nos C; Bourgeois D; Freneaux P; Zafrani B; Salmon RJ; Clough KB
    Bull Cancer; 1999 Jun; 86(6):580-4. PubMed ID: 10417431
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The indocyanine green method is equivalent to the ⁹⁹mTc-labeled radiotracer method for identifying the sentinel node in breast cancer: a concordance and validation study.
    Ballardini B; Santoro L; Sangalli C; Gentilini O; Renne G; Lissidini G; Pagani GM; Toesca A; Blundo C; del Castillo A; Peradze N; Caldarella P; Veronesi P
    Eur J Surg Oncol; 2013 Dec; 39(12):1332-6. PubMed ID: 24184123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Indocyanine green detects sentinel lymph nodes in early breast cancer.
    Liu J; Huang L; Wang N; Chen P
    J Int Med Res; 2017 Apr; 45(2):514-524. PubMed ID: 28415938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Axillary sentinel node and tumour-related factors associated with non-sentinel node involvement in breast cancer.
    Cserni G; Burzykowski T; Vinh-Hung V; Kocsis L; Boross G; Sinkó M; Tarján M; Bori R; Rajtár M; Tekle E; Maráz R; Baltás B; Svébis M
    Jpn J Clin Oncol; 2004 Sep; 34(9):519-24. PubMed ID: 15466825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
    Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
    Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of the indocyanine green dye method versus the combined method of indigo carmine blue dye with indocyanine green fluorescence imaging for sentinel lymph node biopsy in breast conservative therapy for stage ≤IIA breast cancer.
    Takemoto N; Koyanagi A; Yasuda M; Yamamoto H
    BMC Womens Health; 2018 Sep; 18(1):151. PubMed ID: 30227837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved false negative rate of axillary status using sentinel lymph node biopsy and ultrasound-suspicious lymph node sampling in patients with early breast cancer.
    Wang Y; Dong H; Wu H; Zhang L; Yuan K; Chen H; Jiao M; Fu R
    BMC Cancer; 2015 May; 15():382. PubMed ID: 25956308
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sentinel Node Biopsy in Breast Cancer Patients with Clinically Negative Lymph-Nodes.
    Motomura K; Inaji H; Komoike Y; Kasugai T; Nagumo S; Noguchi S; Koyama H
    Breast Cancer; 1999 Jul; 6(3):259-262. PubMed ID: 11091726
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
    Fujii T; Yajima R; Tatsuki H; Kuwano H
    Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence.
    Murawa D; Hirche C; Dresel S; Hünerbein M
    Br J Surg; 2009 Nov; 96(11):1289-94. PubMed ID: 19847873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The relation of visualization of internal mammary lymph nodes on lymphoscintigraphy to axillary lymph node metastases in breast cancer.
    Kim H; Shin MJ; Kim SJ; Kim IJ; Park I
    Lymphat Res Biol; 2014 Dec; 12(4):295-300. PubMed ID: 25144255
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer.
    Shimazu K; Tamaki Y; Taguchi T; Motomura K; Inaji H; Koyama H; Kasugai T; Wada A; Noguchi S
    Ann Surg; 2003 Mar; 237(3):390-8. PubMed ID: 12616124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.